Today's Reuters Health News Headlines - Yahoo! News:
|
|
Adcock Ingram H1 earnings down 10 percent
Mon,28 May 2012 11:33 PM PDT
Reuters - JOHANNESBURG (Reuters) - South Africa's No.2 drug maker Adcock Ingram posted a 10 percent fall half-year earnings on Tuesday, hit by the loss of high-margin drugs and said it would continue seeking acquisitions in emerging markets. Adcock, the nation's top over-the-counter drugs maker, said diluted headline earnings per share totalled 198.4 cents in the six months to end-March, compared with 220.7 cents a year earlier. The company said sales increased 5 percent to 2.25 billion rand. ... Full Story | Top |
Human Genome shareholder files case to restrain "poison pill"
Mon,28 May 2012 10:25 PM PDT
Reuters - (Reuters) - A Human Genome Sciences shareholder has filed a lawsuit against the board and requested a Maryland court to temporarily restrain the company from using a "poison pill" in response to GlaxoSmithKline's hostile $2.6 billion takeover offer. Human Genome adopted the stockholder rights plan earlier this month in an attempt to ward off GlaxoSmithKline in what is becoming an increasingly acrimonious battle between the companies that together sell new Lupus drug Benlysta. ... Full Story | Top |
Common painkillers tied to lower skin cancer risk
Mon,28 May 2012 09:34 PM PDT
Reuters - NEW YORK (Reuters Health) - In a new study from Denmark, people who had taken aspirin, ibuprofen and related painkillers -- especially at high doses and for years at a time -- were less likely to get skin cancer, compared to those who rarely used those medications. The findings add to growing evidence that long-term use of the medications, known as nonsteroidal anti-inflammatory drugs, or NSAIDs, may help protect people against skin cancers, including melanoma, the deadliest type. ... Full Story | Top |
Cannabis fails to slow progress of multiple sclerosis in UK study
Mon,28 May 2012 04:02 PM PDT
Reuters -  LONDON (Reuters) - Cannabis capsules failed to slow the progression of multiple sclerosis in a large British study, dealing a blow to hopes that the drug could provide long-term benefits for patients with the debilitating nerve disease. Despite promising signs in earlier, shorter studies, researchers found patients who took capsules containing tetrahydrocannabinol (THC), a key active ingredient in cannabis, fared no better than those given a placebo. ...
Full Story | Top |
Woodford whistleblowing case delayed by judge
Mon,28 May 2012 11:15 AM PDT
Reuters - LONDON (Reuters) - The case for unfair dismissal brought by former Olympus CEO Michael Woodford following the uncovering of one of Japan's biggest corporate frauds was delayed on Monday, sparking talk of an out-of-court settlement. The employment tribunal began in London, throwing the spotlight back on a $1.7 billion accounting scandal that cost the camera-to-endoscope maker its board and reputation. ... Full Story | Top |
Paladin Labs to sell Nuvo's anesthesia patch in Canada
Mon,28 May 2012 08:11 AM PDT
Reuters - (Reuters) - Nuvo Research Inc said it has granted Paladin Labs Inc , a specialty pharmaceutical company, exclusive rights to market and sell its anesthesia patch in Canada. Paladin will pay Nuvo a double-digit royalty on net sales of the patch in Canada and lend it C$8.0 million in two equal tranches. The loan, which matures in May 2016, will bear an interest of 15 percent per annum. The patch, Synera, uses Nuvo's proprietary controlled heat-assisted drug delivery technology and combines lidocaine, tetracaine. It is approved in the United States for use in superficial dermatological ... Full Story | Top |
Doctors disagree on when to stop PSA screening
Mon,28 May 2012 08:07 AM PDT
Reuters - NEW YORK (Reuters Health) - Doctors vary when it comes to deciding when an older man can stop routine PSA screening for prostate cancer, a new study finds. In the U.S., many men now have their cancer diagnosed at an early stage through screening with prostate-specific antigen (PSA) blood tests. Although that sounds like a good thing, PSA screening is controversial. On Monday, the U.S. ... Full Story | Top |
GSK melanoma drugs may steal market from Roche
Mon,28 May 2012 06:07 AM PDT
Reuters -  LONDON (Reuters) - Two experimental skin cancer drugs from GlaxoSmithKline - each designed to block different pathways used by tumour cells - look set to steal a march on Roche's pioneering melanoma treatment Zelboraf, according to Citigroup. The brokerage, which raised its price target on GSK stock on Monday, forecast combined risk-adjusted annual sales for dabrafenib and trametinib of 1.5 billion pounds ($2.35 billion)by 2020, some three times consensus expectations. ...
Full Story | Top |
Oldest female bodybuilder loves pumping iron
Mon,28 May 2012 02:04 AM PDT
Reuters - NEW YORK (Reuters) - As an active 77 year old, Edith Wilma Connor enjoys doing step aerobics with her great-granddaughter. But pumping iron is the real passion of the oldest female competitive bodybuilder. Full Story | Top |
Friend groups may encourage kids to be more active
Sun,27 May 2012 09:34 PM PDT
Reuters - NEW YORK (Reuters Health) - Kids in after-school programs often increase their own physical activity if they make friends who run and jump around more than they do, a new study from Tennessee has found. Though not completely surprising, that finding could be important as parents, after-school teachers and camp counselors try to encourage youngsters to move more and head-off obesity before it starts, researchers said. The results are also in line with research that's been done in teens and adults, who tend to look like the rest of their friend group in terms of weight and fitness level. ... Full Story | Top |
Pediatricians raise caution on sensory-based therapy
Sun,27 May 2012 09:33 PM PDT
Reuters - NEW YORK (Reuters Health) - Occupational therapy for kids who are over- or under-sensitive to sound, touch or other senses could help improve their symptoms -- but parents and doctors should be careful not to miss an underlying disorder in those children, pediatricians said today. So-called sensory integration therapy, in which occupational therapists use brushes, swings, balls, music and other tools to help kids adapt to external stimuli, has been controversial among doctors. ... Full Story | Top |
Wounded war veterans find brotherhood in softball
Sun,27 May 2012 09:06 PM PDT
Reuters -  COOPERSTOWN, New York (Reuters) - When Saul Bosquez, a 27-year-old U.S. Army veteran who lost part of his left leg in Iraq, stepped up to the plate during a softball game this Memorial Day weekend, he knew he needed a big hit. Bosquez, who plays with the Wounded Warrior Amputee Softball Team and wears a prosthetic leg below his left knee, said the hot weather on Sunday in Cooperstown - home to the Baseball Hall of Fame - was making it harder than usual for him to run the bases. Luckily, the ball soared over the outfielders' heads, and Bosquez made it safely to third. ...
Full Story | Top |
Whistleblower Woodford to tackle Olympus in court
Sun,27 May 2012 07:02 PM PDT
Reuters -  LONDON (Reuters) - Michael Woodford, the ousted chief executive of Olympus , will try to persuade a London judge his embattled former employer fired him because he blew the cover off one of Japan's most high-profile corporate frauds. The five-day hearing, which starts on Monday, will throw the spotlight back onto a $1.7 billion accounting scandal that has cost the camera-to-endoscope maker its board and reputation. Woodford, chief executive for just two weeks before being sacked, is expected to seek up to $60 million in compensation from his former employer, according to the Financial Times. ...
Full Story | Top |
Women get less information on post-cancer fertility: study
Sun,27 May 2012 06:00 PM PDT
Reuters - (Reuters) - Cancer treatment can sometimes lead to infertility, but young women are far less likely than young men to be informed of this, according to a Swedish study. Findings published in the Journal of Clinical Oncology found that of nearly 500 cancer survivors aged 18 to 45, 80 percent of men surveyed said their doctor had told them their chemotherapy could affect their future fertility. But only 48 percent of women said the same. In addition, only 14 percent of women said they received information on options to preserve their fertility, versus 68 percent of men. ... Full Story | Top |
Soy supplement shows no blood pressure benefit: study
Sun,27 May 2012 05:47 PM PDT
Reuters - (Reuters) - Soy-rich diets have been linked to lower rates of heart disease, but soy supplements alone may not do anything for older women's blood pressure, according to a U.S. study. The findings, reported in the American Journal of Clinical Nutrition, add to the mixed evidence on the health benefits of soy isoflavones - compounds that are thought to have weak estrogen-like effects in some body tissue. ... Full Story | Top |
| |
|
No comments:
Post a Comment